Clinical research
Gilead said that the Phase III trial for mild to moderate patients had been ended because of lack of patients to enroll.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 15, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
A preliminary analysis of late-stage trial data shows that BeiGene’s investigational checkpoint inhibitor tislelizumab is hitting the mark as a potential first-line treatment in patients with non-squamous non-small cell lung cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 13, 2020.
The study of the 53 patients in the U.S., Europe and Canada who required respiratory support showed that about two-thirds benefited from the drug.
It was a very busy week for clinical trial news. Here’s a look.
As COVID-19 has swept across the world, companies have had to make significant adjustments to the way business is conducted in a global economy. It has impacted all types of operations, including clinical trials.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.
China’s CanSino Biologics is advancing its COVID-19 vaccine candidate into Phase II, putting the company ahead of others in the race against the novel coronavirus.
PRESS RELEASES